Eltoukhy Helmy
Co-Chief Executive Officer
Eltoukhy Helmy has filed 11 SEC Form 4 filings (45 transaction rows) across 1 company, with disclosures dating back to 2025. 9 of those filings fall inside the rolling window. Most recent filing: Oct 2, 2026.
On the most recent filing, Eltoukhy Helmy is listed as Co-Chief Executive Officer at Guardant Health, Inc. Inside the rolling window, Eltoukhy Helmy reported no open-market purchases and 2 open-market sales totaling $22.0M in GH. The largest disclosed transaction in the window is a sale of 100,000 GH shares on Jun 5, 2026, worth $12.6M.
Companies traded
Other insiders at GH
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$22.0M
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
Frequently asked questions
How many SEC Form 4 filings has Eltoukhy Helmy made?
Eltoukhy Helmy has filed 11 SEC Form 4 filings (45 transaction rows) across 1 company since 2025.
Which companies does Eltoukhy Helmy trade?
Eltoukhy Helmy has filed SEC Form 4 disclosures for 1 company, including GH.
When was Eltoukhy Helmy's most recent SEC Form 4 filing?
Eltoukhy Helmy's most recent SEC Form 4 filing on Tracefour is dated Oct 2, 2026.
What is Eltoukhy Helmy's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Eltoukhy Helmy is listed as Co-Chief Executive Officer.
What is Eltoukhy Helmy's total buy and sell value in the current window?
Inside the rolling retention window, Eltoukhy Helmy bought $0 and sold $22.0M based on SEC Form 4 filings.
What was Eltoukhy Helmy's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 100,000 GH shares on 2026-06-05, worth $12.6M, per SEC Form 4 filings.